Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Claritev (CTEV) Asset Writedowns and Impairment (2022 - 2024)

Claritev (CTEV) has 1 years of Asset Writedowns and Impairment data on record, last reported at $54.5 million in Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $54.5 million; the TTM value through Sep 2025 reached $54.5 million, down 96.2%, while the annual FY2024 figure was $1.5 billion, N/A changed from the prior year.
  • Asset Writedowns and Impairment reached $54.5 million in Q4 2024 per CTEV's latest filing, down from $361.6 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $553.7 million in Q2 2024 and bottomed at $54.5 million in Q4 2024.